| Wed, Nov 18, 2009 | | • | Biotech Stocks Hot Right Now, Ho-Hum in the Long Run
at The Wall Street Journal Online (Wed, Nov 18)
| | Fri, Nov 13, 2009 | | • | Talecris to invest $268.7 million in NC plant
AP (Fri, Nov 13)
| | • | Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Business Wire (Fri, Nov 13)
| | Wed, Nov 11, 2009 | | • | There Will Be Blood (Plasma)
at Motley Fool (Wed, Nov 11)
| | • | Coverage initiated on Talecris Biotherapeutics by Barclays Capital and Citigroup
Briefing.com (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | • | Talecris Biotherapeutics Holdings Corp. Earnings Call scheduled for 8:30 am ET today
CCBN (Tue, Nov 10)
| | • | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial
EDGAR Online (Tue, Nov 10)
| | Mon, Nov 9, 2009 | | • | Talecris Biotherapeutics Announces Third Quarter 2009 Results
Business Wire (Mon, Nov 9)
| | • | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
| | • | Q3 2009 Talecris Biotherapeutics Holdings Corp. Earnings Release - After Market Close
CCBN (Mon, Nov 9)
| | Fri, Oct 30, 2009 | | • | Talecris Biotherapeutics to Report Third Quarter 2009 Financial Results
Business Wire (Fri, Oct 30)
| | Wed, Oct 21, 2009 | | • | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a
EDGAR Online (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | "Best In Class" Formulation Of Fentanyl Seen As Breakthrough Treatment By Ladenburg Thalmann Analyst
Wall Street Transcript (Tue, Oct 20)
| | Mon, Oct 19, 2009 | | • | Talecris says protein deficiency drug approved
AP (Mon, Oct 19)
| | • | Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
PR Newswire (Mon, Oct 19)
| | Fri, Oct 16, 2009 | | • | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Fri, Oct 16)
| | • | Talecris to sell $600M in notes due 2016
AP (Fri, Oct 16)
| | • | Talecris Biotherapeutics Announces Pricing of $600 Million Senior Notes due 2016
Business Wire (Fri, Oct 16)
| | Tue, Oct 13, 2009 | | • | The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
PR Newswire (Tue, Oct 13)
| | • | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Oct 13)
|
Add TLCR News to My Yahoo!:
 
| |
|
0.16% Nasdaq 
0.90 (4.67%) 
Headlines
